Tenaya Therapeutics, Inc.

SEC 4 · Filed

0001193125-26-354518Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Aug 17, 2026

Sale by Ali Faraz

Security
Common Stock
Code
S
Shares
7,406
Price per share
0.71Reported 0.7097
Structured facts
{
  "code": "S",
  "date": "2026-08-17",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F2": "Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $.6820 to $.7253. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.",
    "F8": "Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 3, 2026.",
    "F9": "Includes 262,069 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."
  },
  "owners": [
    {
      "cik": "0001667937",
      "name": "Ali Faraz",
      "roles": [
        "director",
        "officer"
      ],
      "title": "Chief Executive Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "417782",
  "price": "0.7097",
  "row": 4,
  "rule_10b5_1": "false",
  "security": "Common Stock",
  "shares": "7406",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Aug 17, 2026

Sale by Ali Faraz

Security
Common Stock
Code
S
Shares
5,020
Price per share
0.71Reported 0.7097
Structured facts
{
  "code": "S",
  "date": "2026-08-17",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F2": "Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $.6820 to $.7253. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.",
    "F6": "Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 6, 2025.",
    "F7": "Includes 281,894 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."
  },
  "owners": [
    {
      "cik": "0001667937",
      "name": "Ali Faraz",
      "roles": [
        "director",
        "officer"
      ],
      "title": "Chief Executive Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "425188",
  "price": "0.7097",
  "row": 3,
  "rule_10b5_1": "false",
  "security": "Common Stock",
  "shares": "5020",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Aug 17, 2026

Sale by Ali Faraz

Security
Common Stock
Code
S
Shares
3,969
Price per share
0.71Reported 0.7098
Structured facts
{
  "code": "S",
  "date": "2026-08-17",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F2": "Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $.6820 to $.7253. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.",
    "F4": "Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024.",
    "F5": "Includes 295,331 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."
  },
  "owners": [
    {
      "cik": "0001667937",
      "name": "Ali Faraz",
      "roles": [
        "director",
        "officer"
      ],
      "title": "Chief Executive Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "430208",
  "price": "0.7098",
  "row": 2,
  "rule_10b5_1": "false",
  "security": "Common Stock",
  "shares": "3969",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Aug 17, 2026

Sale by Ali Faraz

Security
Common Stock
Code
S
Shares
5,837
Price per share
0.71Reported 0.7097
Structured facts
{
  "code": "S",
  "date": "2026-08-17",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023.",
    "F2": "Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $.6820 to $.7253. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.",
    "F3": "Includes 305,956 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."
  },
  "owners": [
    {
      "cik": "0001667937",
      "name": "Ali Faraz",
      "roles": [
        "director",
        "officer"
      ],
      "title": "Chief Executive Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "434177",
  "price": "0.7097",
  "row": 1,
  "rule_10b5_1": "false",
  "security": "Common Stock",
  "shares": "5837",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}